A possible treatment to a debilitating disease may be found within the next two years thanks to an experimental drug.
Researchers in Boston, Massachusetts, are in the final phase of testing a drug they claim will combat the protein amyloid in the brain, ABC5 in Boston reports. It has been widely reported that researchers believe amyloid could be involved with the development of Alzheimer's disease.
If successful, it is likely to take a couple of years for the drug to be made available. However, a new study suggests there is something people can do to combat the disease today.
Resveratrol, a compound in red wine and grapes, was found to "encourage beta amyloid's breakdown," according to the Natural Health News Report website.
The study was conducted by Dr Philippe Marambaud of New York and inspired by other reports showing that Alzheimer's was rare in populations that moderately consume red wine.
There are currently 700,000 people with dementia in the UK and it is estimated more than a million people will be stricken with the disease by 2025.